Hemab Therapeutics Holdings, Inc. · NASDAQ:COAG

Ra Capital Management, L.P. bought 4,798 Hemab Therapeutics Holdings, Inc. shares (Form 4)

Traded May 19 to May 20, 2026 · Filed May 21, 2026

From May 19 to May 20, 2026, Ra Capital Management, L.P. (10% owner) bought 4,798 Hemab Therapeutics Holdings, Inc. shares at an average US$24.96 for US$120K, leaving 6,376,968 shares. Filed May 21, 2026 (Form 4).

Bought
4,798 shares
Price
US$24.96 average (US$24.94 to US$24.97)
Value
US$120K
Holding after
6,376,968 shares (held indirectly)
Trading plan
No
Role
10% owner

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
May 19, 2026Common StockBuy3,802US$24.976,375,972Indirect
May 20, 2026Common StockBuy996US$24.946,376,968Indirect

Source

View original at SEC

Related